Freda C Lewis-Hall
CIK 1437909 · Executive Vice President · last filed 2026-03-25
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$42.71M
Companies
9
Total Filings
150
Lifetime Open-Market Net
-$310.1K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PYXS | Director | 241,405 | $2.91 | $702.5K | $0 | 6 | 2026-03-25 |
| CDTTW | Director | 39,801 | $0.01 | $454 | $0 | 4 | 2025-08-26 |
| SpringWorks Therapeutics, Inc. (SWTX) Delisted | Director | 4,017,245 | $46.99 | $188.77M | $900.0K | 9 | 2025-07-02 |
| CDT | Director | — | $2.94 | — | $0 | 1 | 2023-12-14 |
| EXACT SCIENCES CORP (EXAS) Delisted | Director | 19,688 | $104.91 | $2.07M | $0 | 5 | 2023-06-12 |
| 1Life Healthcare Inc (ONEM) Delisted | Director | 4,534 | $16.47 | $74.7K | $0 | 3 | 2022-06-06 |
| PFE | Executive Vice President | 468,690 | $25.25 | $11.83M | -$1.10M | 113 | 2019-03-01 |
| THC | Director | 15,314 | $262.63 | $4.02M | $0 | 3 | 2016-05-17 |
| VRTX | EVP, Medicines Development | 53,334 | $490.39 | $26.15M | -$106.3K | 5 | 2009-03-20 |
Recent Filings · Page 2 of 15
150 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-12-14 | CDT | Grant (A) | — | $0 | EDGAR |
| 2023-06-12 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | +3,599 | $0 | EDGAR |
| 2023-05-25 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Grant (A) | +4,648 | $0 | EDGAR |
| 2023-03-28 | PYXS | Grant (A) | +139,355 | $0 | EDGAR |
| 2023-02-24 | — | Disp (D) | −4,534 | -$81.6K | |
| 2022-06-13 | EXACT SCIENCES CORP (EXAS) Delisted | Grant (A) | +5,606 | $0 | EDGAR |
| 2022-06-06 | 1Life Healthcare Inc (ONEM) Delisted | Mixed | +4,534 | $0 | EDGAR |
| 2022-05-20 | SpringWorks Therapeutics, Inc. (SWTX) Delisted | Grant (A) | +4,818 | $0 | EDGAR |
| 2022-04-04 | PYXS | Grant (A) | +66,831 | $0 | EDGAR |
| 2021-10-12 | PYXS | Grant (A) | — | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.